Find NINDS Clinical Trials

Study Title Disorders Status Study Location Clinical Trials ID
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) Completed Multiple U.S. Locations NCT02194010
Discharge Educational Strategies for Reduction of Vascular Events Completed New York NCT01836354
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study Multiple Sclerosis Recruiting Multiple U.S. Locations NCT04754542
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience Recruiting Texas NCT05074485
Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31 Hereditary Spastic Paraplegia Terminated Maryland* NCT02859428
Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism Completed New York NCT00211757
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? Terminated Maryland* NCT03104725
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain Terminated North Carolina NCT01743976
Donepezil to Treat Dementia in Parkinson's Disease Completed Maryland NCT00030979
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI Traumatic Brain Injury (TBI) Terminated Maryland NCT02148783
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI Traumatic Brain Injury (TBI) Completed Maryland NCT02225106
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage Completed Massachusetts NCT00598572
Dosing Study of Replagal in Patients With Fabry Disease Fabry Disease Completed Maryland NCT00068107
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) Multiple Sclerosis Terminated Maryland NCT01212094
Double Blind Trial of DC Polarization in FTD Dementias Completed Maryland NCT00117858
Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy Completed North Carolina NCT01506518
Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor Essential Tremor Completed Maryland NCT00848172
Droxidopa / Pyridostigmine in Orthostatic Hypotension Orthostatic Hypotension Completed Minnesota NCT01370512
Drug and Non-Drug Treatment Of Severe Migraine Completed Ohio NCT00910689
Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed Loop Control of Severe Essential Tremor Essential Tremor Recruiting Florida NCT04212780